BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Liu B, Xie J, Jiang X, Xiao B, Hu X, Xiang J. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling. Mol Med Rep 2022;25:181. [PMID: 35322863 DOI: 10.3892/mmr.2022.12697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bitto N, Ghigliazza G, Lavorato S, Caputo C, La Mura V. Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis. J Clin Med 2023;12. [PMID: 36769582 DOI: 10.3390/jcm12030934] [Reference Citation Analysis]
2 Abd El-fattah EE, Zakaria AY. Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management. J Transl Med 2022;20:544. [DOI: 10.1186/s12967-022-03759-z] [Reference Citation Analysis]
3 Wang S, Zhang J, Chen H, Zhan X, Nie H, Wang C, Zhang Y, Zheng B, Gong Q. MicroRNA-181b promotes schistosomiasis-induced hepatic fibrosis by targeting Smad7. Mol Biochem Parasitol 2022;252:111523. [PMID: 36195241 DOI: 10.1016/j.molbiopara.2022.111523] [Reference Citation Analysis]